Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
28 March, 2017 13:31 IST
Laurus Labs lists at 14% premium
Source: IRIS | 19 Dec, 2016, 10.10AM
Comments  |  Post Comment

Laurus Labs got listed on the stock markets on Thursday with a premium of 14.46% over its issue price. At the NSE, stock opened at Rs 489.90 a share as against issue price of Rs 428.00 a share.

Currently, shares are trading at Rs 477.45, up 11.55% from its issue price. It recorded a high of Rs 498 and a low of Rs 475 at the NSE (10:07 am).

Laurus Labs is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufactures APIs in oncology and other therapeutic areas.

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer